On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
June 11 @ 4:30 pm - 5:30 pm EDT
June 12 @ 12:00 pm - 1:00 pm EDT
- New NYS Hepatitis C Elimination Task Force Website is Live March 8, 2019
- Action Alert | Recruiting New Yorkers for Transgender, Gender Non‐Conforming and Non‐Binary Community Advisory Board @ NYC Health Dept March 5, 2019
- NY City Council Discretionary Funding Application (Due 2/19/19) January 12, 2019